Teneliximab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Teneliximab
Monoclonal antibody
Type Whole antibody
Source Chimeric (mouse/human)
Target CD40
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
 NYesY (what is this?)  (verify)

Teneliximab is a chimeric monoclonal antibody[1] binding to the immune stimulatory protein CD40. As of 2009, it has not entered clinical trials.[2]

References[edit]

  1. ^ International Nonproprietary Names For Pharmaceutical Substances
  2. ^ Iqbal S. Grewal, ed. (January 15, 2009). Therapeutic Targets of the TNF Superfamily (Advances in Experimental Medicine and Biology). Springer. p. 22. ISBN 0-387-89519-1.